Tax-loss harvesting alternatives for HRMY

Among the 28 Biotechnology peers screened, EXEL (Exelixis) has tracked HRMY most closely over the past year, with a return correlation of 0.32. The strongest fund stand-in is XPH (SPDR S&P Pharmaceuticals) at 0.38 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →

STOCKS

Single-name peers

Ticker	Name	Sub-industry	1Y	3Y	5Y	10Y
EXEL	Exelixis	Biotechnology	0.32	0.11	0.18	—
INCY	Incyte	Biotechnology	0.28	0.25	0.26	—
HALO	Halozyme	Biotechnology	0.26	0.23	0.26	—
LGND	Ligand Pharmaceuticals, Inc.	Biotechnology	0.23	0.27	0.26	—
NBIX	Neurocrine Biosciences	Biotechnology	0.23	0.15	0.23	—
VIR	Vir Biotechnology, Inc.	Biotechnology	0.23	0.16	0.15	—
ROIV	Roivant Sciences	Biotechnology	0.21	0.21	0.21	—
XNCR	Xencor Inc	Biotechnology	0.19	0.19	0.24	—
BMRN	BioMarin Pharmaceutical	Biotechnology	0.19	0.21	0.24	—
VRTX	Vertex Pharmaceuticals	Biotechnology	0.19	0.13	0.18	—
KRYS	Krystal Biotech	Biotechnology	0.19	0.15	0.13	—
ADMA	ADMA Biologics, Inc.	Biotechnology	0.18	0.16	0.21	—
RCUS	Arcus Biosciences, Inc.	Biotechnology	0.18	0.20	0.25	—
TGTX	TG Therapeutics, Inc.	Biotechnology	0.18	0.24	0.27	—
PTGX	Protagonist Therapeutics, Inc.	Biotechnology	0.18	0.17	0.16	—
BIIB	Biogen Inc.	Biotechnology	0.17	0.21	0.23	—
CYTK	Cytokinetics	Biotechnology	0.16	0.12	0.18	—
AMGN	Amgen Inc.	Biotechnology	0.14	0.15	0.17	—
SRPT	Sarepta Therapeutics	Biotechnology	0.14	0.05	0.10	—
VCEL	Vericel	Biotechnology	0.14	0.21	0.26	—
ALNY	Alnylam Pharmaceuticals	Biotechnology	0.13	0.12	0.16	—
ARWR	Arrowhead Pharmaceuticals	Biotechnology	0.13	0.20	0.29	—
GILD	Gilead Sciences	Biotechnology	0.12	0.11	0.14	—
RGEN	Repligen	Biotechnology	0.11	0.20	0.24	—
UTHR	United Therapeutics	Biotechnology	0.11	0.10	0.13	—
REGN	Regeneron Pharmaceuticals	Biotechnology	0.11	0.15	0.19	—
FTRE	Fortrea	Biotechnology	0.11	0.16	0.16	—
MRNA	Moderna Inc.	Biotechnology	0.11	0.10	0.11	—

ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

Ticker	Name	Focus	Match	1Y	3Y	5Y	10Y
XPH	SPDR S&P Pharmaceuticals	Pharmaceuticals (Equal Wt)	INDUSTRY	0.38	0.40	0.42	—
XBI	SPDR S&P Biotech ETF	Biotechnology (Equal Wt)	INDUSTRY	0.35	0.34	0.41	—
IBB	iShares Biotechnology ETF	Biotechnology	INDUSTRY	0.35	0.32	0.37	—
IHE	iShares US Pharmaceuticals ETF	Pharmaceuticals	INDUSTRY	0.28	0.29	0.32	—
ARKG	ARK Genomic Revolution ETF	Genomics (Active)	INDUSTRY	0.27	0.29	0.36	—
VHT	Vanguard Health Care ETF	Health Care Sector	SECTOR	0.27	0.27	0.33	—
FHLC	Fidelity MSCI Health Care ETF	Health Care Sector	SECTOR	0.25	0.27	0.32	—
IYH	iShares US Healthcare ETF	Health Care Sector	SECTOR	0.23	0.25	0.30	—
PPH	VanEck Pharma ETF	Pharmaceuticals	INDUSTRY	0.21	0.22	0.25	—
XLV	Health Care Select Sector SPDR	Health Care Sector	SECTOR	0.21	0.24	0.28	—
IHI	iShares Medical Devices ETF	Medical Devices	SUB-IND	0.13	0.20	0.27	—
IHF	iShares Health Care Providers	Health Care Providers	INDUSTRY	0.13	0.17	0.24	—

NEXT STEPS

Harvesting a loss in HRMY?

Estimate what the harvest could save →Check the eight wash-sale traps →Document the trade with a Tax Memo →

Replacement research for HRMY's peers

EXEL INCY HALO LGND NBIX VIR ROIV XNCR BMRN VRTX KRYS ADMA RCUS TGTX PTGX BIIB CYTK AMGN SRPT VCEL ALNY ARWR GILD RGEN UTHR REGN FTRE MRNA

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.